Printable Copy |
This article is part of a numbeer of the American Journal of Tropical Medicine and Hygiene devoted to P. vivax. It may be of special interest to such countries as India, where P. falciparum no longer predominates.
- Author Affiliations
1. 1Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia. 2. 2Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.Discussions beginning in 2012 ultimately led to a landmark document from the World Health Organization (WHO) titled, Control and Elimination of Plasmodium vivax: A Technical Brief, published in July 2015. That body of work represents multiple expert consultations coordinated by the WHO Global Malaria Program, along with technical consensus gathering from national malaria control programs via the WHO regional offices around the globe. That document thus represents thoroughly vetted state-of-the-art recommendations for dealing specifically with P. vivax, the first assembly of such by the WHO. This supplement to the journal was commissioned by the WHO and compiles the very substantial body of evidence and analysis informing those recommendations. This introductory narrative to the supplement provides the historical and technological context of global strategy for combatting P. vivax and reducing the burdens of morbidity and mortality it imposes.
Disclaimer: I served as Chair of the Steering and Writing Committees commissioned by the World Health Organization (WHO) to prepare the Technical Brief. I served as a consultant to WHO in organizing and editing the content of this supplement and was assigned as section editor of it by the journal.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.